United Therapeutics Has Commenced Litigation Related To The FDA Inappropriately Denying United Therapeutics' Right To Obtain Stay Of Liquidia's Final Approval Until United Therapeutics' Pending Patent Infringement Claim Against Liquidia Can Be Resolved
Author: Benzinga Newsdesk | February 21, 2024 06:59am